← All companies

GDTC

CytoMed Therapeutics Limited

GDTC Nasdaq Pharmaceutical Preparations EDGAR ↗

$0.92

-0.01 -1.16%

Key statistics

from XBRL data in SEC filings

Market cap

$10.9M

Revenue (TTM)

—

Net income (TTM)

—

EPS (TTM)

—

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

—

Total assets

—

Gross margin

—

52-week range

$0.68 – $3.68

Recent SEC filings

40 most recent

Annual, quarterly & current reports

6-K Jun 23, 2026 6-K Jun 3, 2026 6-K May 15, 2026 6-K May 11, 2026 6-K Apr 14, 2026 6-K Mar 31, 2026 20-F Mar 31, 2026 6-K Jan 28, 2026 6-K Jan 13, 2026 6-K Dec 8, 2025 6-K Nov 18, 2025 6-K Nov 6, 2025 6-K Oct 22, 2025 6-K Oct 14, 2025 6-K Oct 2, 2025 6-K Sep 30, 2025 6-K Aug 28, 2025 6-K Aug 19, 2025 6-K Jul 21, 2025 6-K Jul 3, 2025 6-K Jul 3, 2025 6-K May 16, 2025 6-K CURRENT REPORT OF FOREIGN ISSUER Apr 28, 2025 20-F Apr 28, 2025 6-K Jan 6, 2025 6-K Dec 5, 2024 6-K Nov 20, 2024 6-K Oct 7, 2024 6-K Oct 3, 2024 6-K Sep 30, 2024 6-K/A Jun 24, 2024 6-K Jun 20, 2024 6-K May 24, 2024 6-K/A Apr 25, 2024 6-K Apr 24, 2024 20-F Apr 22, 2024 6-K Mar 18, 2024 6-K Mar 4, 2024 6-K Jan 29, 2024 6-K Nov 17, 2023